UBS Group AG - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 121 filers reported holding SERES THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$395,406
+12.7%
166,137
+126.9%
0.00%
Q2 2023$350,776
-43.8%
73,231
-33.5%
0.00%
Q1 2023$624,284
-49.6%
110,103
-50.2%
0.00%
Q4 2022$1,238,994
+441.0%
221,249
+518.5%
0.00%
Q3 2022$229,000
+1808.3%
35,773
+887.7%
0.00%
Q2 2022$12,000
-98.2%
3,622
-96.1%
0.00%
Q1 2022$668,000
+1612.8%
93,802
+1913.4%
0.00%
Q4 2021$39,000
-98.6%
4,659
-98.8%
0.00%
-100.0%
Q3 2021$2,755,000
+1350.0%
395,863
+4861.9%
0.00%
Q2 2021$190,000
+13.1%
7,978
-2.7%
0.00%
Q1 2021$168,000
+281.8%
8,198
+355.4%
0.00%
Q4 2020$44,000
-82.7%
1,800
-80.0%
0.00%
Q3 2020$255,000
+8400.0%
8,993
+1184.7%
0.00%
Q2 2020$3,000
-93.3%
700
-94.4%
0.00%
Q1 2020$45,000
-67.6%
12,533
-68.9%
0.00%
Q4 2019$139,000
+58.0%
40,357
+82.6%
0.00%
Q3 2019$88,000
+2100.0%
22,106
+1600.5%
0.00%
Q2 2019$4,000
-71.4%
1,300
-35.0%
0.00%
Q1 2019$14,000
-6.7%
2,000
-37.0%
0.00%
Q4 2018$15,000
+150.0%
3,175
+296.9%
0.00%
Q3 2018$6,000
-75.0%
800
-71.4%
0.00%
Q2 2018$24,000
+60.0%
2,800
+33.3%
0.00%
Q1 2018$15,000
-42.3%
2,100
-19.2%
0.00%
Q4 2017$26,000
-38.1%
2,6000.0%0.00%
Q3 2017$42,000
-26.3%
2,600
-48.9%
0.00%
Q2 2017$57,000
-5.0%
5,088
-4.9%
0.00%
Q1 2017$60,000
+93.5%
5,348
+73.1%
0.00%
Q4 2016$31,000
-36.7%
3,090
-22.8%
0.00%
Q3 2016$49,000
-3.9%
4,003
+128.4%
0.00%
Q2 2016$51,000
+2.0%
1,753
-7.2%
0.00%
Q1 2016$50,000
+31.6%
1,888
+76.6%
0.00%
Q4 2015$38,0001,0690.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders